JPRN-UMIN000025037已完成1 期
A pharmacokinetic study of sodium phenylbutyrate in refractory pediatric cholestasis disease - A pharmacokinetic study of sodium phenylbutyrate in refractory pediatric cholestasis disease
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6months-old 至 216months-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Those who have hypersensitivity with phenylbutylate, its metabolites, drug additives and/or benzoate, etc 2) Subjects with congestive heart failure, kidney failure, and/or hypernatremia with edema 3) Subjects with renal dysfunction 4) Subjects with liver cirrhosis 5) Subjects who have been determined ineligible by principal investigator or sub-investigator
研究者
相似试验
已完成
1 期
A pharmacokinetic study of sodium phenylbutyrate in healthy adults for refractory pediatric cholestatic disease's therapyAdultJPRN-UMIN000027674Juntendo University20
已完成
1 期
A pharmacokinetic study of sodium phenylbutyrate in urea cycle disorderurea cycle disorderJPRN-UMIN000025627Juntendo University5
尚未招募
2 期
Investigating Sodium Butyrate as Treatment for Anorexia NervosaAnorexia NervosaACTRN12624000368538Monash University15
已完成
2 期
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle DisordersAmino Acid Metabolism, Inborn ErrorsNCT00004767National Center for Research Resources (NCRR)20
招募中
3 期
Effect of sodium butyrate in prevention and treatment of type 2 diabetesDiabetes mellitus Type 2.E10, E11,DiabetesIRCT20090609002017N33utrition Research Center, Tabriz University of Medical Science42